123 related articles for article (PubMed ID: 21499191)
1. Central serous chorioretinopathy after renal transplantation.
Lee CS; Kang EC; Lee KS; Byeon SH; Koh HJ; Lee SC
Retina; 2011 Oct; 31(9):1896-903. PubMed ID: 21499191
[TBL] [Abstract][Full Text] [Related]
2. Central serous chorioretinopathy after solid organ transplantation.
Fawzi AA; Holland GN; Kreiger AE; Heckenlively JR; Arroyo JG; Cunningham ET
Ophthalmology; 2006 May; 113(5):805-13.e5. PubMed ID: 16650676
[TBL] [Abstract][Full Text] [Related]
3. Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy.
Koyama M; Mizota A; Igarashi Y; Adachi-Usami E
Ophthalmologica; 2004; 218(2):107-10. PubMed ID: 15004499
[TBL] [Abstract][Full Text] [Related]
4. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.
Han JM; Hwang JM; Kim JS; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):440-5. PubMed ID: 24370828
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.
Fok AC; Chan PP; Lam DS; Lai TY
Ophthalmic Res; 2011; 46(3):160-3. PubMed ID: 21389741
[TBL] [Abstract][Full Text] [Related]
6. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy.
Mudvari SS; Goff MJ; Fu AD; McDonald HR; Johnson RN; Ai E; Jumper JM
Retina; 2007; 27(9):1168-73. PubMed ID: 18046220
[TBL] [Abstract][Full Text] [Related]
7. Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid.
Sato H; Ito S; Nagai S; Murasawa A; Wada Y; Murakami S; Kuroda T; Nakano M; Narita I
Mod Rheumatol; 2013 Jan; 23(1):172-4. PubMed ID: 22447556
[TBL] [Abstract][Full Text] [Related]
8. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
Imamura Y; Fujiwara T; Spaide RF
Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
[TBL] [Abstract][Full Text] [Related]
9. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
[TBL] [Abstract][Full Text] [Related]
10. Clinical factors related to visual outcome in central serous chorioretinopathy.
Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
[TBL] [Abstract][Full Text] [Related]
11. Central serous chorioretinopathy.
Marcuson J; Riley T
Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders.
Schalenbourg A; Leys A; De Courten C; Coutteel C; Herbort CP
Klin Monbl Augenheilkd; 2002 Apr; 219(4):264-7. PubMed ID: 12022014
[TBL] [Abstract][Full Text] [Related]
13. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy.
Behnia M; Khabazkhoob M; Aliakbari S; Abadi AE; Hashemi H; Pourvahidi P
Retina; 2013 Feb; 33(2):324-8. PubMed ID: 23314231
[TBL] [Abstract][Full Text] [Related]
14. Macular pigment optical density in central serous chorioretinopathy.
Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
[TBL] [Abstract][Full Text] [Related]
15. Retinal adaptability loss in serous retinal detachment with central serous chorioretinopathy.
Shimada Y; Imai D; Ota Y; Kanai K; Mori K; Murayama K; Yoneya S
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3210-5. PubMed ID: 20164451
[TBL] [Abstract][Full Text] [Related]
16. Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis.
Kurup SK; Oliver A; Emanuelli A; Hau V; Callanan D
Retina; 2012; 32(10):2096-101. PubMed ID: 22718154
[TBL] [Abstract][Full Text] [Related]
17. Photopigments in central serous chorioretinopathy.
Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
[TBL] [Abstract][Full Text] [Related]
18. Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy.
Değirmenci C; Afrashi F; Nalçacı S; Çeper SB
Turk J Ophthalmol; 2019 Dec; 49(6):367-369. PubMed ID: 31893595
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy.
Lim JW; Kang SW; Kim YT; Chung SE; Lee SW
Br J Ophthalmol; 2011 Apr; 95(4):514-7. PubMed ID: 20644214
[TBL] [Abstract][Full Text] [Related]
20. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy.
Sharma T; Shah N; Rao M; Gopal L; Shanmugam MP; Gopalakrishnan M; Bhende P; Bhende M; Shetty NS; Baluswamy S
Ophthalmology; 2004 Sep; 111(9):1708-14. PubMed ID: 15350327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
